• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas.

作者信息

Blanchi Julie, Taleb Sofiane, Bayle Arnaud, Verret Benjamin, Toulmonde Maud, Spalato-Ceruso Mariella, Dubos Paul, Laizet Yech'an, Alame Melissa, Khalifa Emmanuel, Italiano Antoine

机构信息

INSERM, Unité 1312, SARCOTARGET team, Bordeaux, France.

Department of BioPathology, Institut Bergonié, Bordeaux, France.

出版信息

Cancer Commun (Lond). 2023 Sep;43(9):1051-1054. doi: 10.1002/cac2.12461. Epub 2023 Jul 5.

DOI:10.1002/cac2.12461
PMID:37405935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10508143/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0394/10508143/c42a236ab2cc/CAC2-43-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0394/10508143/c42a236ab2cc/CAC2-43-1051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0394/10508143/c42a236ab2cc/CAC2-43-1051-g001.jpg

相似文献

1
Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft-tissue sarcomas.对晚期软组织肉瘤患者进行大panel循环肿瘤DNA测序的临床应用价值
Cancer Commun (Lond). 2023 Sep;43(9):1051-1054. doi: 10.1002/cac2.12461. Epub 2023 Jul 5.
2
Chasing ctDNA in Patients With Sarcoma.在肉瘤患者中追踪 ctDNA。
Am Soc Clin Oncol Educ Book. 2020 May;40:e351-e360. doi: 10.1200/EDBK_280749.
3
Individualized Mini-Panel Sequencing of ctDNA Allows Tumor Monitoring in Complex Karyotype Sarcomas.ctDNA 个体化小型面板测序可用于复杂核型肉瘤的肿瘤监测。
Int J Mol Sci. 2022 Sep 6;23(18):10215. doi: 10.3390/ijms231810215.
4
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.采用下一代测序技术对软组织肉瘤进行分子谱分析：迈向精准治疗的初步研究。
Hum Pathol. 2014 Aug;45(8):1563-71. doi: 10.1016/j.humpath.2014.04.012. Epub 2014 Apr 24.
5
Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.骨肉瘤和软组织肉瘤中视网膜母细胞瘤基因改变与肿瘤分级的分析。
J Natl Cancer Inst. 1991 Feb 6;83(3):194-200. doi: 10.1093/jnci/83.3.194.
6
Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.循环游离 DNA 的基因分型可实现黏液样脂肪肉瘤的无创性肿瘤检测。
Int J Cancer. 2019 Aug 15;145(4):1148-1161. doi: 10.1002/ijc.32216. Epub 2019 Mar 9.
7
The Circulating Nucleic Acid Characteristics of Non-Metastatic Soft Tissue Sarcoma Patients.非转移性软组织肉瘤患者的循环核酸特征。
Int J Mol Sci. 2020 Jun 24;21(12):4483. doi: 10.3390/ijms21124483.
8
[Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].[软组织肉瘤中染色体异常的检测：哪些肉瘤？哪些异常？如何检测？为何检测？]
Bull Cancer. 2007 Sep;94(9):781-92.
9
Molecular genetics of soft tissue sarcomas.软组织肉瘤的分子遗传学
Cancer Treat Res. 1997;91:31-50. doi: 10.1007/978-1-4615-6121-7_3.
10
Experiences from tissue microarray in soft tissue sarcomas.软组织肉瘤组织芯片的经验
Acta Orthop Scand Suppl. 2004 Apr;75(311):29-34. doi: 10.1080/00016470410001708300.

引用本文的文献

1
Global patterns and burden of soft tissue and extraosseous sarcomas: trends from 1990 to 2021.软组织和骨外肉瘤的全球模式与负担：1990年至2021年的趋势
BMC Cancer. 2025 Apr 17;25(1):725. doi: 10.1186/s12885-025-14136-6.
2
Novel Molecular Methods in Soft Tissue Sarcomas: From Diagnostics to Theragnostics.软组织肉瘤的新型分子方法：从诊断到治疗诊断学
Cancers (Basel). 2025 Apr 3;17(7):1215. doi: 10.3390/cancers17071215.
3
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort.

本文引用的文献

1
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.软组织肉瘤和骨肿瘤患者临床基因组分析的管理。
Nat Commun. 2022 Jun 15;13(1):3406. doi: 10.1038/s41467-022-30496-0.
2
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin.FoundationOne Liquid CDx 的临床和分析验证，一种新型的基于 324 个基因 cfDNA 的用于实体瘤来源的癌症的全面基因组分析检测方法。
PLoS One. 2020 Sep 25;15(9):e0237802. doi: 10.1371/journal.pone.0237802. eCollection 2020.
3
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
通过全面基因组分析整合胚系、组织和液体活检分析，以提高真实世界癌症队列中可操作变异的检出率。
J Transl Med. 2024 May 15;22(1):462. doi: 10.1186/s12967-024-05227-2.
4
Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors.骨与软组织肿瘤分子病理学的当前挑战与实际问题
Virchows Arch. 2024 Feb;484(2):353-367. doi: 10.1007/s00428-024-03736-5. Epub 2024 Jan 16.
血浆游离 DNA 下一代测序在胃肠道间质瘤中的临床价值。
BMC Cancer. 2020 Feb 5;20(1):99. doi: 10.1186/s12885-020-6597-x.
4
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).一种将基因组改变分级为癌症精准医学治疗靶点的框架：ESMO 分子靶向治疗临床可操作性评分（ESCAT）。
Ann Oncol. 2018 Sep 1;29(9):1895-1902. doi: 10.1093/annonc/mdy263.
5
Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group.循环肿瘤 DNA 的检测与尤文肉瘤和骨肉瘤的不良预后相关：来自儿童肿瘤协作组的报告。
Br J Cancer. 2018 Aug;119(5):615-621. doi: 10.1038/s41416-018-0212-9. Epub 2018 Aug 21.
6
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors.体细胞结构变异的检测有助于对实体瘤患儿循环肿瘤DNA进行定量和特征分析。
JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00285. Epub 2018 Jul 5.
7
Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.软组织肉瘤成人患者的靶向改变：个性化治疗的见解。
JAMA Oncol. 2018 Oct 1;4(10):1398-1404. doi: 10.1001/jamaoncol.2018.0723.
8
Patterns of care and outcomes of patients with METAstatic soft tissue SARComa in a real-life setting: the METASARC observational study.真实环境中转移性软组织肉瘤患者的治疗模式及结局：METASARC观察性研究
BMC Med. 2017 Apr 10;15(1):78. doi: 10.1186/s12916-017-0831-7.
9
Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.血浆中的癌症基因组扫描：通过大规模平行测序检测肿瘤相关拷贝数异常、单核苷酸变异和肿瘤异质性。
Clin Chem. 2013 Jan;59(1):211-24. doi: 10.1373/clinchem.2012.196014. Epub 2012 Oct 11.